Skip to content
The Barcelona Debates on the Human Microbiome 2023 Logo The Barcelona Debates on the Human Microbiome 2023 Logo
  • Home
  • Faculty
    • Organizer
    • Coordinators
    • Scientific Committee
  • Program
  • Registration
  • Abstracts
  • Support
  • Practical Info
  • Previous Editions
    • 2019
      • Organizer 2019
      • Practical Info
      • Sponsors 2019
      • Collaborators
      • Program
      • Speakers and Chairs
      • Scientific Committee 2019
      • Coordinators 2019
      • Material Downloads
    • 2020
      • Home 2020
      • Faculty 2020
        • Organizer 2020
        • Coordinators 2020
        • Speakers 2020
      • Program 2020
      • Support 2020
      • Practical Info 2020
    • 2022
      • Home 2022
      • Faculty 2022
        • Organizer 2022
        • Coordinators 2022
        • Scientific Committee 2022
        • Speakers 2022
      • Program 2022
      • Support 2022
      • Practical Info 2022

Program 2019

Home/Program 2019
Program 2019sarah moreira2022-02-28T09:37:13+00:00
Download Program in PDF

Thursday 20th June 2019

8.30

Registration Front Desk

9.15

Welcome Àngel Font, La Caixa Banking Foundation.

(TBD), Departament de Salut – Generalitat de Catalunya, Spain.

Roger Paredes, IrsiCaixa.  Hospital Germans Trias i Pujol. Fight AIDS Foundation. Badalona, Spain.

Francisco Guarner, Vall d’Hebron Research Institute (VHIR). Barcelona, Spain.

Session 1: Immune Modulation CHAIR: Bonaventura Clotet, IrsiCaixa.  Hospital Germans Trias i Pujol. Fight AIDS Foundation. Badalona, Spain

9.30

–

10.30

Vaccines and the microbiome Dario Gutierrez, Merck Exploratory Science Center. Cambridge, MA, USA.
Multiple Sclerosis Hartmut Wekerle, Max Planck Institute of Neurobiology. Munich, Germany.

10.30-11.00

Overall discussion
11.00-11.30

Coffee Break

Session 2: Cancer CHAIR: Josep Tabernero, Vall d’Hebron Institute of Oncology (VHIO). Barcelona, Spain.

11.30

–

12.30

Microbiome in colon cancer Alberto Martin, University of Toronto, Canada.
Microbiome and immune checkpoint inhibitors Laurence Zitvogel, Institut Gustave Roussy. Paris, France.

12.30-13.00

Overall discussion
13.00-14.00

Lunch and poster viewing

Session 3: Cancer CHAIR: Paolo G. Nuciforo, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain.

14.00

–

15.00

Implications of the gut and oral microbiome dysbiosis in pancreatic cancer aetiology Esther Molina-Montes, Spanish National Cancer Research Centre (CNIO). Madrid, Spain.
Intratumor bacteria and cancer therapeutics Ravid Straussman, Weizmann Institute of Science. Rehovot, Israel.

15.00-15.30

Overall discussion
15.30-16.00

Coffee Break

Session 4: Digestive Diseases CHAIRS: J. M. Fernandez Real, Dr. Josep Trueta Girona University Hospital. Spain

Natalia Borruel, Vall d’Hebron University Hospital. Barcelona, Spain.

16.00

–

17.00

Inflammatory bowel disease (IBD) Harry Sokol, Saint-Antoine Hospital. Paris, France
Metabolic disorders and fatty liver Tony Wu, Institute of Medicine, University of Gothenburg, Sweden.

17.00-17.30

Overall discussion
17.30

Adjourn

Friday 21st June 2019

Session 5: Compositional Analysis CHAIRS: M. Luz Calle, University of Vic. Spain

Marc Noguera i Julian, IrsiCaixa. Badalona, Spain.

9.30

–

10.30

Why microbiome data are compositional? Vera Pawlowsky-Glahn, University of Girona, Spain.
Causes and implication of compositionality on microbiome interpretation Gregory Gloor, University of Western Ontario, Canada.

10.30-11.00

Overall discussion
11.00-11.30

Coffee Break

Session 6: Infectious Diseases CHAIR: Roger Paredes, IrsiCaixa. Hospital Germans Trias i Pujol. Fight AIDS Foundation. badalona, Spain.

11.30

–

12.30

Effects of FMT on antimicrobial resistance clearance Grzegorz Basak, Medical University of Warsaw, Poland.
Microbiome transmission in the immunocompromised host Ami S. Bhatt, Stanford Medical School. California, USA.

12.30-13.00

Overall discussion
13.00-14.00

Lunch and poster viewing

Session 7: Functional Analysis CHAIRS: Chaysavanh Manichanh, Vall d’Hebron Research Institute (VHIR). Barcelona, Spain.

M. Carmen Collado, Institute of Agrochemistry and Food Technology (IATA-CSIC). Valencia, Spain.

14.00

–

15.00

The gut metabolome in HIV infection Marc Noguera i Julian, IrsiCaixa. Badalona, Spain.
Systems Ecology of the Human Microbiome Paul Wilmes, Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg.

15.00-15.30

Overall discussion

15.30-16.00

Translating microbiome science – Insights into The future Joël Doré, French National Institute for Agricultural Research (INRA). France.

16.00-16.30

Meeting Closure Francisco Guarner, Vall d’Hebron Research Institute (VHIR). Barcelona, Spain.

Title

Thanks to the support of

La Caixa
© Copyright    |   FLS-Science   |   PRIVACY POLICY   |   TERMS AND CONDITIONS   |   ALL RIGHTS RESERVED 

The logistics of the meeting as well as this website are managed by FLS-Science, and entity of FLS (www.flsida.org) for more information contact us at or visit www.fls-science.com

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Page load link
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}
0
    0
    Your Cart
    Your cart is empty
    Go to Top